| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
|
Kotsakis, Athanasios
|
|
2010
|
68 |
2 |
p. 415-422
|
artikel
|
| 2 |
Anticancer effect of (E)-2-hydroxy-3′,4,5′-trimethoxystilbene on breast cancer cells by mitochondrial depolarization
|
Chae, Yee Soo
|
|
2010
|
68 |
2 |
p. 349-358
|
artikel
|
| 3 |
Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase
|
Kim, Yon Hui
|
|
2010
|
68 |
2 |
p. 405-413
|
artikel
|
| 4 |
Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells
|
Bai, Li-Yuan
|
|
2010
|
68 |
2 |
p. 489-496
|
artikel
|
| 5 |
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors
|
Kulke, Matthew H.
|
|
2010
|
68 |
2 |
p. 293-300
|
artikel
|
| 6 |
Clinical benefit of early phase clinical trial participation for advanced sarcoma patients
|
Jones, Robin L.
|
|
2010
|
68 |
2 |
p. 423-429
|
artikel
|
| 7 |
Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
|
Chang, Myung Hee
|
|
2010
|
68 |
2 |
p. 317-323
|
artikel
|
| 8 |
Conjugation of chlorin p6 to histamine enhances its cellular uptake and phototoxicity in oral cancer cells
|
Parihar, Arpana
|
|
2010
|
68 |
2 |
p. 359-369
|
artikel
|
| 9 |
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells
|
Messner, Maria C.
|
|
2010
|
68 |
2 |
p. 477-487
|
artikel
|
| 10 |
Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatography–tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity
|
Serdar, Muhittin A.
|
|
2010
|
68 |
2 |
p. 525-529
|
artikel
|
| 11 |
Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles
|
Lu, Cui-Tao
|
|
2010
|
68 |
2 |
p. 343-348
|
artikel
|
| 12 |
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice
|
Touil, Yasmine S.
|
|
2010
|
68 |
2 |
p. 445-455
|
artikel
|
| 13 |
Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
|
Bilici, Ahmet
|
|
2010
|
68 |
2 |
p. 309-316
|
artikel
|
| 14 |
Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias
|
Waud, William R.
|
|
2010
|
68 |
2 |
p. 399-403
|
artikel
|
| 15 |
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
|
Shitara, Kohei
|
|
2010
|
68 |
2 |
p. 301-307
|
artikel
|
| 16 |
Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability
|
Kim, Kyu-pyo
|
|
2010
|
68 |
2 |
p. 285-291
|
artikel
|
| 17 |
Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors
|
Yuan, Yuan
|
|
2010
|
68 |
2 |
p. 371-378
|
artikel
|
| 18 |
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
|
Ocean, Allyson J.
|
|
2010
|
68 |
2 |
p. 379-388
|
artikel
|
| 19 |
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
|
Tanioka, M.
|
|
2010
|
68 |
2 |
p. 505-511
|
artikel
|
| 20 |
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
|
Andreopoulou, Eleni
|
|
2010
|
68 |
2 |
p. 457-463
|
artikel
|
| 21 |
Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer
|
Boasberg, Peter D.
|
|
2011
|
68 |
2 |
p. 547-552
|
artikel
|
| 22 |
Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination
|
Jia, Lee
|
|
2010
|
68 |
2 |
p. 513-524
|
artikel
|
| 23 |
Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling
|
Shin, Beom Soo
|
|
2010
|
68 |
2 |
p. 465-475
|
artikel
|
| 24 |
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, Ghassan K.
|
|
2011
|
68 |
2 |
p. 539-545
|
artikel
|
| 25 |
Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats
|
Sun, Jong-Mu
|
|
2010
|
68 |
2 |
p. 531-538
|
artikel
|
| 26 |
Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy
|
Tanioka, Maki
|
|
2010
|
68 |
2 |
p. 337-342
|
artikel
|
| 27 |
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models
|
Na, Young-Soon
|
|
2010
|
68 |
2 |
p. 389-398
|
artikel
|
| 28 |
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention
|
Peirce, Susan K.
|
|
2010
|
68 |
2 |
p. 325-335
|
artikel
|
| 29 |
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
|
Van, Trung The
|
|
2010
|
68 |
2 |
p. 497-504
|
artikel
|
| 30 |
The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations
|
Tsallas, Antonia
|
|
2010
|
68 |
2 |
p. 431-444
|
artikel
|
| 31 |
UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
|
Sunakawa, Yu
|
|
2010
|
68 |
2 |
p. 279-284
|
artikel
|
| 32 |
Vascular normalization: a real benefit?
|
Ribatti, Domenico
|
|
2011
|
68 |
2 |
p. 275-278
|
artikel
|
Tijdschrift beschrijving